Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CON, PDT, LIC, JVN

HelixVMtm teams up with Columbia University to enhance its medical marketplace, fortifying triage clearinghouse and fast-tracking patient care


NEW YORK, Sept. 12, 2023 /PRNewswire/ -- HelixVMtm, a virtual health care marketplace, is partnering with Columbia University's accelerator, HITLAB, to elevate medical marketplace innovation. 

This partnership further enhances HelixVM's cutting-edge medical marketplace, focusing on streamlining triage clearing for healthcare providers and expediting FastTrackRxtm prescriptions for patients.

The HelixVM marketplace integrates AI, providing physicians with a seamless triage-clearing process that enhances timely decision-making, patient care, and resource allocation. This includes multi-channel patient intake, catering to both in-store and remote patients. The AI-driven e-Triage clearinghouse facilitates fast track medical consultations for busy providers within their own EMR ecosystem. This leads to 50-75% reduction in time providers spend on tasks like charting, diagnosis, and treatment. This encompasses in-house or third-party claims-assignment for patients covered by insurance.

Furthermore, the FastTrackRxtm prescription feature offered by HelixVM aims to empower patients with a convenient and expedited prescription process. Through this innovative solution, patients can receive necessary prescriptions promptly, enhancing their overall healthcare experience and ensuring timely access to vital medications.

Robert Rodriguez, Founder and CEO of HelixVM, expressed his excitement about the collaboration, stating, "Partnering with HITLAB and Columbia University is a significant step forward in our mission to reshape the healthcare technology landscape. This collaboration will enable us to leverage top-tier research and innovation to provide unparalleled solutions for healthcare providers and patients alike."

Stan Kachnowski, PhD MPA, Director of HITLAB, commented, "We are thrilled to join forces with HelixVM in their journey to drive healthcare innovation forward. By combining our expertise and resources, we are confident that our partnership will yield transformative advancements in medical technology."

This partnership marks the beginning of an exciting chapter for HelixVM and HITLAB, as they work together to redefine the healthcare technology landscape and create a more efficient, patient-centered medical marketplace.

About HelixVM
HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor's visit, from their phone, while using insurance.

Learn more at helixvm.com.

About HITLAB
HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners.

SOURCE HelixVM


These press releases may also interest you

at 07:15
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...

at 07:05
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...

at 07:05
BPGbio, a leading biology-first AI-powered biopharma that focuses on oncology, neurology, and rare diseases, announced today the publication of a significant, multi-year research effort titled "Identification and validation of N-acetylputrescine in...

at 07:05
Septerna, a biotechnology company discovering and advancing novel, oral small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that the company will present the first preclinical data on the company's parathyroid...

at 07:00
In recognition of Clinical Trials Day, The Trial for #ClinicalEquality ?a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company ? continues the fight to increase equity in clinical trials with the next phase of...

at 07:00
The InterMed Group ("InterMed" or the "Company"), a leading provider of healthcare technology management services, proudly announces the appointment of Michael Koffler as its new Chief Executive Officer....



News published on and distributed by: